Left ventricular aneurysm (LVA) is a common complication of myocardial infarction. Traditional medical and surgical treatments are not effective or require high doctors' operational skills and patients' physical fitness. With the development of minimally invasive medical devices, it becomes possible for revivent TC system to treat LVA and reconstruct the left ventricle. This study introduces an existing product and its defect when used. From the perspective of clinical needs, we propose a new design of revivent TC system which realizes accurate force measurement and simplifies surgery.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3969/j.issn.1671-7104.2021.04.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Patient selection for LIVE therapy: From clinical indications to multimodality imaging individual case planning.
Echocardiography
September 2021
Department of Cardiology, Heart Valve Center, University Medical Center Mainz, Mainz, Germany.
Background: Less Invasive Ventricular Enhancement (LIVE) with Revivent TC is an innovative therapy for symptomatic ischemic heart failure (HF). It is designed to reconstruct a negatively remodeled left ventricle (LV) after an anterior myocardial infarction (MI) by plication of the scar tissue. Its indications are specific, and as with any other structural heart intervention, the success of the procedure starts with appropriate patient selection.
View Article and Find Full Text PDF[New Design of Revivent TC System].
Zhongguo Yi Liao Qi Xie Za Zhi
July 2021
Shanghai MicroPort Co. Ltd., Shanghai, 201203.
Left ventricular aneurysm (LVA) is a common complication of myocardial infarction. Traditional medical and surgical treatments are not effective or require high doctors' operational skills and patients' physical fitness. With the development of minimally invasive medical devices, it becomes possible for revivent TC system to treat LVA and reconstruct the left ventricle.
View Article and Find Full Text PDFFirst Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping.
Ann Thorac Surg
August 2021
Cardiovascular Division, Department of Internal Medicine, University of Minnesota, Minneapolis, Minnesota.
The Revivent TC System (BioVentrix Inc, San Ramon, CA) enables a less invasive approach for left ventricular reshaping and scar exclusion in selected patients with ischemic cardiomyopathy. Although the system is designed to improve quality of life and to promote reverse remodeling, patients can still progress to end-stage heart failure requiring advanced therapies. This report describes a case of left ventricular assist device surgery in a patient 16 months after Revivent System implantation.
View Article and Find Full Text PDFLess invasive ventricular reconstruction for ischaemic heart failure.
Eur J Heart Fail
December 2019
DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Germany.
Aims: Surgical ventricular reconstruction to remodel, reshape, and reduce ventricular volume is an effective therapy in selected patients with chronic heart failure (HF) of ischaemic aetiology. The BioVentrix Revivent TC System offers efficacy comparable to conventional surgical ventricular reconstruction and is less invasive utilizing micro-anchor pairs to exclude scarred myocardium on the beating heart. Here, we present 12-months follow-up data of an international multicenter study.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!